Century Enka Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 12, 2025, 8:25 pm

Competitors of Century Enka Ltd

All Competitor Stocks of Century Enka Ltd

Quarterly Result

Last Updated: August 1, 2025, 10:50 pm

Below is a detailed analysis of the quarterly data for Century Enka Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 402.00 Cr.. The value appears to be declining and may need further review. It has decreased from 444.00 Cr. (Mar 2025) to 402.00 Cr., marking a decrease of 42.00 Cr..
• For Expenses, as of Jun 2025, the value is 382.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 435.00 Cr. (Mar 2025) to 382.00 Cr., marking a decrease of 53.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 11.00 Cr..
• For OPM %, as of Jun 2025, the value is 5.00%. The value appears strong and on an upward trend. It has increased from 2.00% (Mar 2025) to 5.00%, marking an increase of 3.00%.
• For Other Income, as of Jun 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 14.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2025) to 19.00 Cr., marking an increase of 10.00 Cr..
• For Tax %, as of Jun 2025, the value is 19.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 19.00%, marking a decrease of 8.00%.
• For Net Profit, as of Jun 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 8.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 7.02. The value appears strong and on an upward trend. It has increased from 3.16 (Mar 2025) to 7.02, marking an increase of 3.86.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 5:33 pm

Growth

Last Updated: September 5, 2025, 1:45 am

Balance Sheet

Last Updated: November 9, 2025, 1:49 pm

Below is a detailed analysis of the balance sheet data for Century Enka Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 22.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 22.00 Cr..
• For Reserves, as of Sep 2025, the value is 1,418.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,400.00 Cr. (Mar 2025) to 1,418.00 Cr., marking an increase of 18.00 Cr..
• For Borrowings, as of Sep 2025, the value is 36.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 37.00 Cr. (Mar 2025) to 36.00 Cr., marking a decrease of 1.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 277.00 Cr.. The value appears to be improving (decreasing). It has decreased from 327.00 Cr. (Mar 2025) to 277.00 Cr., marking a decrease of 50.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 1,753.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,786.00 Cr. (Mar 2025) to 1,753.00 Cr., marking a decrease of 33.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 771.00 Cr.. The value appears to be declining and may need further review. It has decreased from 788.00 Cr. (Mar 2025) to 771.00 Cr., marking a decrease of 17.00 Cr..
• For CWIP, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
• For Investments, as of Sep 2025, the value is 450.00 Cr.. The value appears strong and on an upward trend. It has increased from 413.00 Cr. (Mar 2025) to 450.00 Cr., marking an increase of 37.00 Cr..
• For Other Assets, as of Sep 2025, the value is 518.00 Cr.. The value appears to be declining and may need further review. It has decreased from 571.00 Cr. (Mar 2025) to 518.00 Cr., marking a decrease of 53.00 Cr..
• For Total Assets, as of Sep 2025, the value is 1,753.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,786.00 Cr. (Mar 2025) to 1,753.00 Cr., marking a decrease of 33.00 Cr..

Notably, the Reserves (1,418.00 Cr.) exceed the Borrowings (36.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Century Enka Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 30.42. This value is within the healthy range. It has increased from 19.56 (Mar 24) to 30.42, marking an increase of 10.86.
• For Diluted EPS (Rs.), as of Mar 25, the value is 30.42. This value is within the healthy range. It has increased from 19.56 (Mar 24) to 30.42, marking an increase of 10.86.
• For Cash EPS (Rs.), as of Mar 25, the value is 55.87. This value is within the healthy range. It has increased from 44.00 (Mar 24) to 55.87, marking an increase of 11.87.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 648.76. It has increased from 624.43 (Mar 24) to 648.76, marking an increase of 24.33.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 648.76. It has increased from 624.43 (Mar 24) to 648.76, marking an increase of 24.33.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 916.11. It has increased from 798.24 (Mar 24) to 916.11, marking an increase of 117.87.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 69.60. This value is within the healthy range. It has increased from 53.22 (Mar 24) to 69.60, marking an increase of 16.38.
• For PBIT / Share (Rs.), as of Mar 25, the value is 44.44. This value is within the healthy range. It has increased from 30.22 (Mar 24) to 44.44, marking an increase of 14.22.
• For PBT / Share (Rs.), as of Mar 25, the value is 42.37. This value is within the healthy range. It has increased from 27.77 (Mar 24) to 42.37, marking an increase of 14.60.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 30.71. This value is within the healthy range. It has increased from 21.00 (Mar 24) to 30.71, marking an increase of 9.71.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 30.42. This value is within the healthy range. It has increased from 19.57 (Mar 24) to 30.42, marking an increase of 10.85.
• For PBDIT Margin (%), as of Mar 25, the value is 7.59. This value is below the healthy minimum of 10. It has increased from 6.66 (Mar 24) to 7.59, marking an increase of 0.93.
• For PBIT Margin (%), as of Mar 25, the value is 4.85. This value is below the healthy minimum of 10. It has increased from 3.78 (Mar 24) to 4.85, marking an increase of 1.07.
• For PBT Margin (%), as of Mar 25, the value is 4.62. This value is below the healthy minimum of 10. It has increased from 3.47 (Mar 24) to 4.62, marking an increase of 1.15.
• For Net Profit Margin (%), as of Mar 25, the value is 3.35. This value is below the healthy minimum of 5. It has increased from 2.63 (Mar 24) to 3.35, marking an increase of 0.72.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.32. This value is below the healthy minimum of 8. It has increased from 2.45 (Mar 24) to 3.32, marking an increase of 0.87.
• For Return on Networth / Equity (%), as of Mar 25, the value is 4.68. This value is below the healthy minimum of 15. It has increased from 3.13 (Mar 24) to 4.68, marking an increase of 1.55.
• For Return on Capital Employeed (%), as of Mar 25, the value is 6.22. This value is below the healthy minimum of 10. It has increased from 4.37 (Mar 24) to 6.22, marking an increase of 1.85.
• For Return On Assets (%), as of Mar 25, the value is 3.73. This value is below the healthy minimum of 5. It has increased from 2.53 (Mar 24) to 3.73, marking an increase of 1.20.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.16. It has increased from 1.05 (Mar 24) to 1.16, marking an increase of 0.11.
• For Current Ratio (X), as of Mar 25, the value is 4.07. This value exceeds the healthy maximum of 3. It has decreased from 4.57 (Mar 24) to 4.07, marking a decrease of 0.50.
• For Quick Ratio (X), as of Mar 25, the value is 2.64. This value exceeds the healthy maximum of 2. It has decreased from 3.02 (Mar 24) to 2.64, marking a decrease of 0.38.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.85. This value is within the healthy range. It has increased from 4.36 (Mar 24) to 6.85, marking an increase of 2.49.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 32.87. This value is within the healthy range. It has decreased from 51.11 (Mar 24) to 32.87, marking a decrease of 18.24.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 17.99. This value is below the healthy minimum of 20. It has decreased from 23.49 (Mar 24) to 17.99, marking a decrease of 5.50.
• For Earning Retention Ratio (%), as of Mar 25, the value is 67.13. This value is within the healthy range. It has increased from 48.89 (Mar 24) to 67.13, marking an increase of 18.24.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 82.01. This value exceeds the healthy maximum of 70. It has increased from 76.51 (Mar 24) to 82.01, marking an increase of 5.50.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 33.50. This value is within the healthy range. It has increased from 21.73 (Mar 24) to 33.50, marking an increase of 11.77.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 15.78. This value is within the healthy range. It has increased from 9.58 (Mar 24) to 15.78, marking an increase of 6.20.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,214.55. It has increased from 921.42 (Mar 24) to 1,214.55, marking an increase of 293.13.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 1. It has increased from 0.52 (Mar 24) to 0.60, marking an increase of 0.08.
• For EV / EBITDA (X), as of Mar 25, the value is 7.99. This value is within the healthy range. It has increased from 7.92 (Mar 24) to 7.99, marking an increase of 0.07.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.50 (Mar 24) to 0.59, marking an increase of 0.09.
• For Retention Ratios (%), as of Mar 25, the value is 67.12. This value is within the healthy range. It has increased from 48.88 (Mar 24) to 67.12, marking an increase of 18.24.
• For Price / BV (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1. It has increased from 0.64 (Mar 24) to 0.83, marking an increase of 0.19.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.50 (Mar 24) to 0.59, marking an increase of 0.09.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness